276 related articles for article (PubMed ID: 33120389)
1. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
Wenninger S; Stahl K; Montagnese F; Schoser B
Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
3. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
[TBL] [Abstract][Full Text] [Related]
4. High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study.
Berends J; Tieleman AA; Horlings CGC; Smulders FHP; Voermans NC; van Engelen BGM; Raaphorst J
Neuromuscul Disord; 2019 Oct; 29(10):758-765. PubMed ID: 31540818
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic odyssey of patients with myotonic dystrophy.
Hilbert JE; Ashizawa T; Day JW; Luebbe EA; Martens WB; McDermott MP; Tawil R; Thornton CA; Moxley RT
J Neurol; 2013 Oct; 260(10):2497-504. PubMed ID: 23807151
[TBL] [Abstract][Full Text] [Related]
6. A Greek National Cross-Sectional Study on Myotonic Dystrophies.
Papadimas GK; Papadopoulos C; Kekou K; Kartanou C; Kladi A; Nitsa E; Sofocleous C; Tsanou E; Sarmas I; Kaninia S; Chroni E; Tsivgoulis G; Kimiskidis V; Arnaoutoglou M; Stefanis L; Panas M; Koutsis G; Karadima G; Traeger-Synodinos J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555146
[TBL] [Abstract][Full Text] [Related]
7. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
8. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
[TBL] [Abstract][Full Text] [Related]
9. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
10. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal involvement is frequent in Myotonic Dystrophy type 2.
Tieleman AA; van Vliet J; Jansen JB; van der Kooi AJ; Borm GF; van Engelen BG
Neuromuscul Disord; 2008 Aug; 18(8):646-9. PubMed ID: 18602828
[TBL] [Abstract][Full Text] [Related]
12. Prediction of respiratory impairment in myotonic dystrophies using the 'Respiratory involvement symptom checklist' (Respicheck).
Gutschmidt K; Wirner-Piotrowski C; Angarita NG; Montagnese F; Schoser B; Wenninger S
Neuromuscul Disord; 2023 Jul; 33(7):610-618. PubMed ID: 37399783
[TBL] [Abstract][Full Text] [Related]
13. Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries.
Higgs C; Hilbert JE; Wood L; Martens WB; Marini-Bettolo C; Nikolenko N; Alsaggaf R; Lochmüller H; Moxley RT; Greene MH; Wang Y; Gadalla SM
Front Neurol; 2019; 10():1071. PubMed ID: 31681146
[No Abstract] [Full Text] [Related]
14. High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.
Hilbert JE; Barohn RJ; Clemens PR; Luebbe EA; Martens WB; McDermott MP; Parkhill AL; Tawil R; Thornton CA; Moxley RT;
Neurology; 2017 Sep; 89(13):1348-1354. PubMed ID: 28855409
[TBL] [Abstract][Full Text] [Related]
15. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
[TBL] [Abstract][Full Text] [Related]
16. [Educational and Professional Qualifications of Adults With Myotonic Dystrophies - A Misleading Perception by the Myopathic Face?].
Stahl K; Wenninger S; Schüller A; Montagnese F; Schoser B
Fortschr Neurol Psychiatr; 2016 Apr; 84(4):211-6. PubMed ID: 27100845
[TBL] [Abstract][Full Text] [Related]
17. [Myotonic dystrophy type 2].
Kimura T
Rinsho Shinkeigaku; 2012; 52(11):1267-9. PubMed ID: 23196585
[TBL] [Abstract][Full Text] [Related]
18. Speech and language abnormalities in myotonic dystrophy: An overview.
Hanoun S; Sun Y; Ebrahimi F; Ghasemi M
J Clin Neurosci; 2022 Feb; 96():212-220. PubMed ID: 34789418
[TBL] [Abstract][Full Text] [Related]
19. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
Suominen T; Bachinski LL; Auvinen S; Hackman P; Baggerly KA; Angelini C; Peltonen L; Krahe R; Udd B
Eur J Hum Genet; 2011 Jul; 19(7):776-82. PubMed ID: 21364698
[TBL] [Abstract][Full Text] [Related]
20. Milestones of progression in myotonic dystrophy type 1 and type 2.
Hamel JI; McDermott MP; Hilbert JE; Martens WB; Luebbe E; Tawil R; Moxley RT; Thornton CA
Muscle Nerve; 2022 Oct; 66(4):508-512. PubMed ID: 35778789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
